Chugai Pharmaceutical Co Ltd
TSE:4519
Chugai Pharmaceutical Co Ltd
TSE:4519
Price:
5 094 JPY
1.35%
Market Closed
Updated:
May 5, 2024
Chugai Pharmaceutical Co Ltd
Net Income (Common)
|
Chugai Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Comparables:
4502
4568
4578
4523
4503
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Income (Common)
¥325.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
20%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Income (Common)
¥178.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
2%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Income (Common)
¥186.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
23%
|
CAGR 10-Years
5%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Income (Common)
¥121.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
|
Eisai Co Ltd
TSE:4523
|
Net Income (Common)
¥45.4B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
1%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Net Income (Common)
¥37.3B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
See Also
What is Chugai Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
325.5B
JPY
325.5B
JPY
Based on the financial report for Dec 31, 2023, Chugai Pharmaceutical Co Ltd's Net Income (Common) amounts to 325.5B JPY.
What is Chugai Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
20%
20%
Over the last year, the Net Income (Common) growth was -13%. The average annual Net Income (Common) growth rates for Chugai Pharmaceutical Co Ltd have been 15% over the past three years , 29% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
